Plasmapheresis for lupus retinal vasculitis.
Papadaki
Thekla G
TG
Ocular Immunology and Uveitis Foundation, Massachusetts Eye Research and Surgery Institute, Cambridge, MA 02142, USA.
Zacharopoulos
Ioannis P
IP
Papaliodis
George
G
Iaccheri
Barbara
B
Fiore
Tito
T
Foster
C Stephen
CS
D000328:Adult; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000628:therapy*; D008875:Middle Aged; D010956:Plasmapheresis / Q000379:methods*; D031300:Retinal Vasculitis / Q000209:etiology / Q000628:therapy*
D007166:Immunosuppressive Agents; D003520:Cyclophosphamide